Literature DB >> 24823382

Hemodynamic performance of Trifecta: single-center experience of 400 patients.

Amit Modi1, Mindaugas Budra2, Szabolcs Miskolczi2, Theodore Velissaris2, Markku Kaarne2, Clifford W Barlow2, Steven A Livesey2, Sunil K Ohri2, Geoffrey M Tsang2.   

Abstract

OBJECTIVE: To evaluate postoperative hemodynamic gradients and early outcomes of aortic valve replacement with the Trifecta bioprosthesis.
METHODS: Between 2011 and 2013, 400 patients underwent aortic valve replacement with a Trifecta bioprosthesis. Gradients were calculated by transthoracic echocardiography before discharge. Data were collected retrospectively; patients with postoperative severe left ventricular dysfunction or > mild mitral regurgitation were excluded.
RESULTS: The mean age was 75.9 ± 8.5 years, 197 (49.25%) patients were male, and 140 (35%) were >80-years old. Concomitant procedures were performed in 207 (51.75%) patients, and 30 (7.5%) had redo procedures. Supraannular aortoplasty with bovine pericardium was necessary in 25 (6.25%) cases. Hospital mortality was 2.75% (11 patients). Postoperative peak and mean gradients were 21.7 ± 9.3 and 11.1 ± 4.3 mm Hg for 19-mm valves (n = 29); 19.5 ± 7 and 9.7 ± 3.6 mm Hg for 21-mm valves (n = 158); 17.3 ± 6.6 and 8.7 ± 3.2 mm Hg for 23-mm valves (n = 134); 15.1 ± 6.1 and 7.8 ± 3.3 mm Hg for 25-mm valves (n = 56); 13.2 ± 3.7 and 6.9 ± 2.6 mm Hg for 27-mm valves (n = 11). Nine patients had trivial and one had mild transvalvular regurgitation. Mean follow-up was 1 ± 0.62 years; no patient required reoperation. Kaplan-Meier survival at 1 and 2 years was 94.3% ± 1.3% and 93.7% ± 1.4%.
CONCLUSION: Early postoperative gradients are low after Trifecta implantation. Significant transvalvular regurgitation was not observed, but the incidence of supraannular aortoplasty may be increased.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Aortic valve insufficiency; aortic valve stenosis; bioprosthesis; heart valve prosthesis implantation; treatment outcome

Mesh:

Year:  2014        PMID: 24823382     DOI: 10.1177/0218492314533684

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  7 in total

Review 1.  Pure Cusp Tear of Trifecta Bioprosthesis 2 Years after Aortic Valve Replacement.

Authors:  Masaki Hamamoto; Taira Kobayashi; Masamichi Ozawa; Kosuke Yoshimura
Journal:  Ann Thorac Cardiovasc Surg       Date:  2016-12-14       Impact factor: 1.520

2.  Clinical outcome and hemodynamic performance of St. Jude Trifecta aortic prosthesis: short-term follow-up and risk factors analysis.

Authors:  Paolo Nardi; Calogera Pisano; Fabio Bertoldo; Sara Rita Vacirca; Monica Greci; Carlo Bassano; Antonio Scafuri; Antonio Pellegrino; Giovanni Ruvolo
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Pulmonary Valve Replacement With a Trifecta Valve Is Associated With Reduced Transvalvular Gradient.

Authors:  Brian C Gulack; Ehsan Benrashid; Robert D B Jaquiss; Andrew J Lodge
Journal:  Ann Thorac Surg       Date:  2016-08-25       Impact factor: 4.330

4.  Trifecta St. Jude medical® aortic valve in pulmonary position.

Authors:  Antonio F Corno; Alan G Dawson; Aidan P Bolger; Branco Mimic; Suhair O Shebani; Gregory J Skinner; Simone Speggiorin
Journal:  Nano Rev Exp       Date:  2017-05-01

5.  Numerical and in-vitro experimental assessment of the performance of a novel designed expanded-polytetrafluoroethylene stentless bi-leaflet valve for aortic valve replacement.

Authors:  Guangyu Zhu; Munirah Binte Ismail; Masakazu Nakao; Qi Yuan; Joon Hock Yeo
Journal:  PLoS One       Date:  2019-01-30       Impact factor: 3.240

6.  Early and mid-term haemodynamic performance and clinical outcomes of St. Jude Medical Trifecta™ valve.

Authors:  Renata Raimundo; Soraia Moreira; Francisca Saraiva; Rui J Cerqueira; Pedro Teixeira; Elson Salgueiro; André Lourenço; Mário J Amorim; Jorge Almeida; Paulo Pinho; Adelino F Leite-Moreira
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

7.  St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry.

Authors:  Giovanni Mariscalco; Silvia Mariani; Samuele Bichi; Andrea Biondi; Andrea Blasio; Paolo Borsani; Fabrizio Corti; Benedetta De Chiara; Riccardo Gherli; Cristian Leva; Claudio Francesco Russo; Giordano Tasca; Paolo Vanelli; Ottavio Alfieri; Carlo Antona; Germano Di Credico; Giampiero Esposito; Amando Gamba; Luigi Martinelli; Lorenzo Menicanti; Giovanni Paolini; Cesare Beghi
Journal:  J Cardiothorac Surg       Date:  2015-11-20       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.